http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-574389-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8357c79568c61ef7fd3548ab06e0b728 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate | 2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa145bb0ed2f7c4cd132ef5c1d841653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c5e4f1e10ba12422ac4a6995e1b1aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a590594a2ae52a6150e328f3e031a015 |
| publicationDate | 2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-574389-A |
| titleOfInvention | Antiviral use of cationic surfactant |
| abstract | Disclosed is a cationic surfactant of formula 2 which is derived from the condensation of fatty acids and esterified dibasic amino acids for the manufacture of a medicament for the treatment of virus infections in animals or human beings. The variables are as disclosed in the description. Also disclosed in the use of the cationic surfactant for treating products that may be affected by virus contamination and the method of treating a non-human animal for a virus infection using a cationic surfactant of formula 2. |
| priorityDate | 2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 254.